Thomas Goebel

Thomas Goebel is a Principal at Omega Funds, where he focuses on executing venture capital investments within the specialized life sciences and biotechnology sectors. Operating within a dedicated healthcare investment team, he collaborates with established industry professionals such as Paulina Hill, Michelle Doig, Bernard Davitian, and Claudio Nessi to identify emerging market opportunities. In his capacity as a key investor at the prominent venture capital firm, Goebel evaluates prospective portfolio companies that are actively developing novel therapeutics, diagnostics, and advanced medical technologies. His core investment strategy centers on providing essential capital to early and growth-stage enterprises that are advancing critical healthcare solutions and complex biological research initiatives. Goebel currently dedicates his professional efforts to expanding the broader Omega Funds portfolio by supporting innovative biotech ventures and driving strategic life sciences investments across the global healthcare ecosystem.